Security
WAT · WATERS CORP /DE/
WATNYSECommon stockCurrentCIK 1000697Updated Sep 26, 2026
WAT price & chart
Loading TradingView…
NYSE:WAT on TradingView ↗About the company
Waters Corporation (NYSE: WAT) is a global leader in life sciences and diagnostics, dedicated to accelerating the benefits of pioneering science through analytical technologies, informatics, and service. With a focus on regulated, high-volume testing environments, our innovative portfolio harnesses deep scientific expertise across chemistry, physics, and biology. We collaborate with customers around the world to advance the release of effective, high-quality medicines, ensure the safety of food and water, and drive better patient outcomes by detecting diseases earlier, managing routine infections, and combating antibiotic resistance. Through a shared culture of relentless innovation, our passionate team of ~16,000 colleagues turn scientific challenges into breakthroughs that improve lives worldwide.
In the news
Waters Shareholders Approve Combination with BD's Biosciences & Diagnostic Solutions Business USA - English USA - English News provided by Waters Corporation Jan 27, 2026, 09:25 ET Share this article Share to X Share this article Share to X Waters Corporation's Q4 2025 Financial Results Conference C ↗
Recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 5,076,550,000Source | 4,553,795,000Source | 4,626,854,000Source | 3,281,453,000Source |
| Property, Plant and Equipment, NetUSD | 642,046,000Source | 651,200,000Source | 639,073,000Source | 582,217,000Source |
| GoodwillUSD | 1,340,081,000Source | 1,295,720,000Source | 1,305,446,000Source | 430,328,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 558,179,000Source | 567,906,000Source | 629,187,000Source | 227,399,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 587,831,000Source | 324,421,000Source | 395,076,000Source | 480,529,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 828,844,000Source | 733,365,000Source | 702,168,000Source | 722,892,000Source |
| Inventory, NetUSD | 572,371,000Source | 477,261,000Source | 516,236,000Source | 455,710,000Source |
| Assets, CurrentUSD | 2,147,645,000Source | 1,669,111,000Source | 1,752,867,000Source | 1,763,903,000Source |
| Operating Lease, Right-of-Use AssetUSD | 80,764,000Source | 74,193,000Source | 84,591,000Source | 86,506,000Source |
| Other Assets, NoncurrentUSD | 307,835,000Source | 295,665,000Source | 215,690,000Source | 191,100,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 2,515,308,000Source | 2,725,288,000Source | 3,476,513,000Source | 2,776,965,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 1,632,000Source | 1,630,000Source | 1,627,000Source | 1,624,000Source |
| Retained Earnings (Accumulated Deficit)USD | 10,431,284,000Source | 9,788,655,000Source | 9,150,821,000Source | 8,508,587,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -125,451,000Source | -155,283,000Source | -134,120,000Source | -141,572,000Source |
| Stockholders' Equity Attributable to ParentUSD | 2,561,242,000Source | 1,828,507,000Source | 1,150,341,000Source | 504,488,000Source |
| Additional Paid in Capital, Common StockUSD | 2,416,237,000Source | 2,341,298,000Source | 2,266,265,000Source | 2,199,824,000Source |
| Liabilities and EquityUSD | 5,076,550,000Source | 4,553,795,000Source | 4,626,854,000Source | 3,281,453,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 1,239,499,000Source | 789,758,000Source | 789,580,000Source | 785,737,000Source |
| Operating Lease, Liability, CurrentUSD | 31,091,000Source | 25,537,000Source | 27,825,000Source | 26,429,000Source |
| Accounts Payable, CurrentUSD | 103,778,000Source | 99,931,000Source | 84,705,000Source | 93,302,000Source |
| Operating Lease, Liability, NoncurrentUSD | 52,548,000Source | 50,317,000Source | 58,926,000Source | 62,108,000Source |
| Other Liabilities, NoncurrentUSD | 197,823,000Source | 183,796,000Source | 137,812,000Source | 117,543,000Source |
| Additional Financial Items | ||||
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 588,000,000Source | 325,000,000Source | 396,000,000Source | 481,000,000Source |
| Deferred Tax Liabilities, NetUSD | 98,208,000Source | 95,823,000Source | 84,596,000Source | 79,706,000Source |
| Long-term Debt, Excluding Current Maturities | — | — | — | — |
| Long-term Debt, Excluding Current MaturitiesUSD | 947,445,000Source | 1,626,488,000Source | 2,305,513,000Source | 1,524,878,000Source |
| Short-term InvestmentsUSD | — | 934,000Source | 898,000Source | 862,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | 642,629,000Source | 637,834,000Source | 642,234,000Source | 707,755,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | 54,127,000Source | 44,709,000Source | 36,868,000Source | 42,564,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 55,498,000Source | 66,240,000Source | -49,179,000Source | 137,874,000Source |
| Increase (Decrease) in InventoriesUSD | 65,933,000Source | -20,943,000Source | 45,443,000Source | 101,902,000Source |
| Deferred Income Tax Expense (Benefit)USD | -14,657,000Source | -877,000Source | -1,197,000Source | -31,988,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 652,555,000Source | 762,123,000Source | 602,809,000Source | 611,661,000Source |
| Cash flows from investing activities: | ||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | 35,053,000Source | 0Source | 1,282,354,000Source | 0Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -152,253,000Source | -144,023,000Source | -1,442,265,000Source | -107,967,000Source |
| Cash flows from financing activities: | ||||
| Payments for Repurchase of Common StockUSD | 14,667,000Source | 13,541,000Source | 70,277,000Source | 626,061,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -237,205,000Source | -696,675,000Source | 754,951,000Source | -509,633,000Source |
| Repayments of Long-term DebtUSD | 290,000,000Source | 900,000,000Source | 670,040,000Source | 145,000,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 262,476,000Source | -70,655,000Source | -85,453,000Source | -20,705,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 587,831,000Source | 324,421,000Source | 395,076,000Source | 480,529,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 44,648,000Source | 92,096,000Source | 94,099,000Source | 48,083,000Source |
| Income Taxes Paid, NetUSD | 244,236,000Source | 183,341,000Source | 243,316,000Source | 160,082,000Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | -621,000Source | 7,920,000Source | -948,000Source | -14,766,000Source |
| Additional Financial Items | ||||
| AmortizationUSD | 118,093,000Source | 104,807,000Source | 81,280,000Source | 58,425,000Source |
| Share-based Payment Arrangement, ExpenseUSD | 54,127,000Source | 44,709,000Source | 36,868,000Source | 42,564,000Source |
| Amortization of Intangible AssetsUSD | 118,000,000Source | 105,000,000Source | 81,000,000Source | 58,000,000Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 588,000,000Source | 325,000,000Source | 396,000,000Source | 481,000,000Source |
| DepreciationUSD | 88,144,000Source | 87,018,000Source | 84,625,000Source | 71,998,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | 28,000,000Source | 36,000,000Source | -16,000,000Source | -31,000,000Source |
| Gain (Loss) Related to Litigation SettlementUSD | 0Source | -11,568,000Source | 0Source | 0Source |
| GoodwillUSD | 1,340,081,000Source | 1,295,720,000Source | 1,305,446,000Source | 430,328,000Source |
| Impairment of Intangible Assets, Finite-livedUSD | — | — | 4,000,000Source | — |
| Income Tax Expense (Benefit)USD | 112,249,000Source | 117,034,000Source | 94,009,000Source | 130,091,000Source |
| Inventory Write-downUSD | 6,000,000Source | 14,000,000Source | 11,000,000Source | 14,000,000Source |
| Investment Income, InterestUSD | 18,777,000Source | 17,416,000Source | 16,621,000Source | 11,020,000Source |
| Net Income (Loss) Attributable to ParentUSD | 642,629,000Source | 637,834,000Source | — | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | 642,629,000Source | 637,834,000Source | 642,234,000Source | 707,755,000Source |
| Nonoperating Income (Expense)USD | 3,061,000Source | 776,000Source | 807,000Source | 2,228,000Source |
| Other Nonoperating Income (Expense)USD | 3,061,000Source | 776,000Source | 807,000Source | 2,228,000Source |
| Payments of Financing CostsUSD | 16,000,000Source | — | — | — |
| Payments to Acquire InvestmentsUSD | 0Source | 3,729,000Source | 1,791,000Source | 11,407,000Source |
| Proceeds from Issuance of Long-term DebtUSD | 70,000,000Source | 170,000,000Source | 1,450,040,000Source | 205,000,000Source |
| Proceeds from Stock Options ExercisedUSD | 10,000,000Source | 21,000,000Source | 18,000,000Source | 32,000,000Source |
| Realized Investment Gains (Losses)USD | — | 0Source | 742,000Source | — |
| Unrealized Gain (Loss) on InvestmentsUSD | — | — | 0Source | 0Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 3,165,286,000Source | 2,958,387,000Source | 2,956,416,000Source | 2,971,956,000Source |
| Cost of RevenueUSD | 1,288,822,000Source | 1,200,201,000Source | 1,195,223,000Source | 1,248,182,000Source |
| Gross Profit (Calculated) · Derived | — | — | — | — |
| Selling, General and Administrative ExpenseUSD | 830,374,000Source | 690,148,000Source | 736,014,000Source | 658,026,000Source |
| Operating Income (Loss)USD | 802,588,000Source | 826,353,000Source | 817,676,000Source | 873,395,000Source |
| Other Nonoperating Income (Expense)USD | 3,061,000Source | 776,000Source | 807,000Source | 2,228,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | 754,878,000Source | 754,868,000Source | 736,243,000Source | 837,846,000Source |
| Income Tax Expense (Benefit)USD | 112,249,000Source | 117,034,000Source | 94,009,000Source | 130,091,000Source |
| Net Income (Loss) Attributable to ParentUSD | 642,629,000Source | 637,834,000Source | — | — |
| Earnings Per Share, BasicUSD per share | 10.8Source | 10.75Source | 10.87Source | 11.8Source |
| Earnings Per Share, DilutedUSD per share | 10.76Source | 10.71Source | 10.84Source | 11.73Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 59,509,000Source | 59,333,000Source | 59,076,000Source | 59,985,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 59,706,000Source | 59,552,000Source | 59,270,000Source | 60,331,000Source |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 118,000,000Source | 105,000,000Source | 81,000,000Source | 58,000,000Source |
| Costs and ExpensesUSD | 2,362,698,000Source | 2,132,034,000Source | 2,138,740,000Source | 2,098,561,000Source |
| Current Income Tax Expense (Benefit)USD | 126,906,000Source | 117,911,000Source | 95,206,000Source | 162,079,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | 28,000,000Source | 36,000,000Source | -16,000,000Source | -31,000,000Source |
| Gain (Loss) Related to Litigation SettlementUSD | 0Source | -11,568,000Source | 0Source | 0Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | 57,267,000Source | 121,630,000Source | 74,119,000Source | 133,816,000Source |
| Interest ExpenseUSD | 69,548,000Source | 89,677,000Source | 98,861,000Source | 48,797,000Source |
| Interest Income (Expense), NetUSD | -47,710,000Source | -71,485,000Source | — | — |
| Investment Income, InterestUSD | 18,777,000Source | 17,416,000Source | 16,621,000Source | 11,020,000Source |
| Labor and Related ExpenseUSD | 645,147,000Source | 596,381,000Source | — | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | 642,629,000Source | 637,834,000Source | 642,234,000Source | 707,755,000Source |
| Nonoperating Income (Expense)USD | 3,061,000Source | 776,000Source | 807,000Source | 2,228,000Source |
| Other ExpensesUSD | 790,791,000Source | 628,552,000Source | — | — |
| Realized Investment Gains (Losses)USD | — | 0Source | 742,000Source | — |
| Research and Development ExpenseUSD | 195,711,000Source | 183,027,000Source | 174,945,000Source | 176,190,000Source |
Offerings
Registration 333-292087
Filing attachments
d163377dex991.htm · 8-K · 2026-08-04
EX-99.1 2 d163377dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 For Immediate Release Contact: Caspar Tudor, Head of Investor Relations - (508) 482-3448 Waters Corporation (NYSE: WAT) Reports Second Quarter 2026 Financial Results Second Quarter 2026 Highlights Total reported revenue of $1.645 billion surpassed the high end of the guidance range, driven by broad-based outperformance across both organic revenue and the acquired businesses. Organic revenue of $828 million grew 7% as repor…
Read attachment ↗d131836dex991.htm · 8-K · 2026-05-05
EX-99.1 2 d131836dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 For Immediate Release Contact: Caspar Tudor, Head of Investor Relations - (508) 482-3448 Waters Corporation (NYSE: WAT) Reports First Quarter 2026 Financial Results First Quarter 2026 Highlights Total reported revenue of $1.267 billion exceeded the high end of the guidance range by $56 million, driven by strong outperformance in both organic revenue and the acquired businesses. Organic revenue grew 13% as reported and 11…
Read attachment ↗d70582dex41.htm · 8-K · 2026-03-23
EX-4.1 3 d70582dex41.htm EX-4.1 EX-4.1 Exhibit 4.1 AUGUSTA SPINCO CORPORATION as Company WATERS CORPORATION as Parent Guarantor INDENTURE dated as of March 23, 2026 DEBT SECURITIES U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION as Trustee TRUST INDENTURE ACT CROSS-REFERENCE TABLE * Trust Indenture Act Section Indenture Section 310(a)(1) 7.09 (a)(2) 7.09 (a)(3) N.A. (a)(4) …
Read attachment ↗d70582dex42.htm · 8-K · 2026-03-23
EX-4.2 4 d70582dex42.htm EX-4.2 EX-4.2 Exhibit 4.2 AUGUSTA SPINCO CORPORATION as Company WATERS CORPORATION as Parent Guarantor WATERS TECHNOLOGIES CORPORATION TA INSTRUMENTS - WATERS L.L.C. WATERS ASIA LIMITED WYATT TECHNOLOGY, LLC ACCURI CYTOMETERS, INC. AUGUSTA LIFE SCIENCES US OPCO I LLC AUGUSTA LIFE SCIENCES US OPCO II LLC AUGUSTA LIFE SCIENCES US SPINCO LLC CELLULAR RESEARCH, INC. HANDYLAB, INC. PHARMINGEN as Subsidiary Guarantors and U.S. BANK TRUST COMPANY, NATIONA…
Read attachment ↗d122710dex991.htm · 8-K · 2026-03-16
EX-99.1 2 d122710dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 INDEX TO CONDENSED COMBINED FINANCIAL STATEMENTS Item Page Condensed Combined Statements of Income for the three months ended December F-2 31, 2025 and 2024 (Unaudited) Condensed Combined Statements of Comprehensive Income for the three months F-3 ended December 31, 2025 and 2024 (Unaudited) Condense…
Read attachment ↗d122710dex992.htm · 8-K · 2026-03-16
EX-99.2 3 d122710dex992.htm EX-99.2 EX-99.2 Exhibit 99.2 MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS OF THE BDS BUSINESS The following discussion and analysis should be read in conjunction with the sections entitled “Item 1A. Risk Factors” and “Forward-Looking Statements” in the Annual Report on Form 10-K for the year ended December 31, 2025 filed by Waters Corporation (“Waters”) with the Securities and Exchange Commission (the “SEC”) on February…
Read attachment ↗